Cystic fibrosis (CF) patients who had fasting blood sugar (glucose) levels that rose more quickly throughout adolescence were more…
Lindsey Shapiro, PhD
Lindsey earned her PhD in neuroscience from Emory University in Atlanta, where she studied novel therapeutic strategies for treatment-resistant forms of epilepsy. She was awarded a fellowship from the American Epilepsy Society in 2019 for this research. Lindsey also previously worked as a postdoctoral researcher, studying the role of inflammation in epilepsy and Alzheimer’s disease.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Lindsey Shapiro, PhD
Among women with cystic fibrosis (CF) who experienced a pregnancy, those that were unplanned were associated with an increased…
Chemical signaling within the protective clusters formed by Pseudomonas aeruginosa — a common infection-causing bacteria in cystic fibrosis…
Nearly 39,000 people were estimated to be living with cystic fibrosis (CF) in the U.S. in 2020, up from…
A better growth trajectory over the first years of life was associated with more favorable lung function at age 6…
A single round of airway clearance therapy (ACT) led to immediate improvements in some lung function tests for cystic…
Teenagers and young adults with cystic fibrosis (CF) appear less likely to smoke cigarettes — tobacco or electronic — and…
Cystic fibrosis (CF) patients with CF-related diabetes (CFRD) had a higher gastrointestinal (GI) symptom burden than patients who…
In-school use of airway clearance therapy (ACT) improved a number of health outcomes for children with cystic fibrosis…
At least three months of using the triple combination therapy Trikafta (elexacaftor/tezacaftor/ivacaftor) significantly increased glucose tolerance — reflecting better…